%0 Journal Article
%K Acedapsone
%K Albendazole
%K Amoxicillin
%K Artemether
%K Artemisinins
%K Arterolane
%K Artesunate
%K Azithromycin
%K Azoles
%K Balapiravir
%K CURE ID
%K Celgosivir
%K Chloroquine
%K Clarithromycin
%K Clavulanate
%K Dapsone
%K Diethylcarbamazine
%K Disulfiram
%K Doxycycline
%K Drug reprofiling
%K Drug repurposing
%K Fluconazole
%K Imatinib
%K Isavuconazonium
%K Itraconazole
%K Ivermectin
%K Ketoconazole
%K Levamisole
%K Lumefantrine
%K Mebendazole
%K Mefloquine
%K Moxidectin
%K Moxifloxacin
%K neglected topical diseases
%K Nitazoxanide
%K Off-Label Use
%K Oxamniquine
%K Oxantel
%K Piperaquine
%K Posaconazole
%K Praziquantel
%K Pyrantel pamoate
%K Ravuconazole
%K Ribavirin
%K Rifampicin
%K Rifapentine
%K Sparfloxacin
%K Streptomycin
%K Tribendimidine
%K UV-4B
%B Parasites & vectors
%D 2023
%G eng
%N 1
%P 1-22
%R 10.1186/s13071-023-05909-8
%T The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
%U https://parasitesandvectors.biomedcentral.com/counter/pdf/10.1186/s13071-023-05909-8.pdf
%V 16
%1 <p>https://www.ncbi.nlm.nih.gov/pubmed/37907954</p>

%8 10/2023